Wednesday, 6 April 2022
Home »
Health
,
Health news
,
IFTTT
,
NYT
» The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.
The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.
By BY ADEEL HASSAN from NYT Health https://ift.tt/feQRFiK
0 comments:
Post a Comment